These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 27896591)
1. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer. Timur SS; Bhattarai P; Gürsoy RN; Vural İ; Khaw BA Pharm Res; 2017 Feb; 34(2):352-364. PubMed ID: 27896591 [TBL] [Abstract][Full Text] [Related]
2. Bispecific antibody complex pre-targeting and targeted delivery of polymer drug conjugates for imaging and therapy in dual human mammary cancer xenografts: targeted polymer drug conjugates for cancer diagnosis and therapy. Khaw BA; Gada KS; Patil V; Panwar R; Mandapati S; Hatefi A; Majewski S; Weisenberger A Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1603-16. PubMed ID: 24643779 [TBL] [Abstract][Full Text] [Related]
3. Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates. Patil V; Gada K; Panwar R; Varvarigou A; Majewski S; Weisenberger A; Ferris C; Tekabe Y; Khaw BA Eur J Nucl Med Mol Imaging; 2012 May; 39(5):824-39. PubMed ID: 22302089 [TBL] [Abstract][Full Text] [Related]
4. In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates. Patil V; Gada K; Panwar R; Majewski S; Tekabe Y; Varvarigou A; Khaw BA J Drug Target; 2013 Dec; 21(10):1012-21. PubMed ID: 23863118 [TBL] [Abstract][Full Text] [Related]
5. Bispecific antibody complex pre-targeted delivery of polymer-drug conjugates for cancer therapy. Gada KS; Patil V; Panwar R; Hatefi A; Khaw BA Drug Deliv Transl Res; 2012 Feb; 2(1):65-76. PubMed ID: 25786600 [TBL] [Abstract][Full Text] [Related]
6. Imaging doxorubicin and polymer-drug conjugates of doxorubicin-induced cardiotoxicity with bispecific anti-myosin-anti-DTPA antibody and Tc-99m-labeled polymers. Panwar R; Bhattarai P; Patil V; Gada K; Majewski S; Khaw BA J Nucl Cardiol; 2019 Aug; 26(4):1327-1344. PubMed ID: 29392624 [TBL] [Abstract][Full Text] [Related]
7. An in vitro demonstration of overcoming drug resistance in SKOV3 TR and MCF7 ADR with targeted delivery of polymer pro-drug conjugates. Bhattarai P; Vance D; Hatefi A; Khaw BA J Drug Target; 2017 Jun; 25(5):436-450. PubMed ID: 27937085 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer. Timur SS; Yöyen-Ermiş D; Esendağlı G; Yonat S; Horzum U; Esendağlı G; Gürsoy RN Eur J Pharm Biopharm; 2019 Mar; 136():138-146. PubMed ID: 30660694 [TBL] [Abstract][Full Text] [Related]
9. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy. Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810 [TBL] [Abstract][Full Text] [Related]
10. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor. Yan Z; Wang F; Wen Z; Zhan C; Feng L; Liu Y; Wei X; Xie C; Lu W J Control Release; 2012 Jan; 157(1):118-25. PubMed ID: 21827801 [TBL] [Abstract][Full Text] [Related]
11. Multistage Continuous Targeting with Quantitatively Controlled Peptides on Chitosan-Lipid Nanoparticles with Multicore-Shell Nanoarchitecture for Enhanced Orally Administrated Anticancer In Vitro and In Vivo. Su CW; Yen CS; Chiang CS; Hsu CH; Chen SY Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27634372 [TBL] [Abstract][Full Text] [Related]
12. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck. Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307 [TBL] [Abstract][Full Text] [Related]
13. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio. Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630 [TBL] [Abstract][Full Text] [Related]
14. LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics. Wang Z; Yu Y; Ma J; Zhang H; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Mol Pharm; 2012 Sep; 9(9):2646-57. PubMed ID: 22853186 [TBL] [Abstract][Full Text] [Related]
15. Functionalized nanoscale β-1,3-glucan to improve Her2+ breast cancer therapy: In vitro and in vivo study. Nasrollahi Z; Mohammadi SR; Mollarazi E; Yadegari MH; Hassan ZM; Talaei F; Dinarvand R; Akbari H; Atyabi F J Control Release; 2015 Mar; 202():49-56. PubMed ID: 25597638 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of the antitumor efficacy of peptide-doxorubicin conjugates with different linkers. Liang Y; Li S; Wang X; Zhang Y; Sun Y; Wang Y; Wang X; He B; Dai W; Zhang H; Wang X; Zhang Q J Control Release; 2018 Apr; 275():129-141. PubMed ID: 29408580 [TBL] [Abstract][Full Text] [Related]
17. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes. Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178 [TBL] [Abstract][Full Text] [Related]
18. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer. Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487 [TBL] [Abstract][Full Text] [Related]
19. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin. Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482 [TBL] [Abstract][Full Text] [Related]
20. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Xiong XB; Ma Z; Lai R; Lavasanifar A Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]